0001209191-21-064924.txt : 20211116
0001209191-21-064924.hdr.sgml : 20211116
20211116201752
ACCESSION NUMBER: 0001209191-21-064924
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211116
FILED AS OF DATE: 20211116
DATE AS OF CHANGE: 20211116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOWE CHRISTOPHER P.
CENTRAL INDEX KEY: 0001376260
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38890
FILM NUMBER: 211418040
MAIL ADDRESS:
STREET 1: 2511 N LOOP 1604,
STREET 2: SUITE 204
CITY: SAN ANTONIO
STATE: TX
ZIP: 78258
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cortexyme, Inc.
CENTRAL INDEX KEY: 0001662774
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 269 EAST GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-910-5717
MAIL ADDRESS:
STREET 1: 269 EAST GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-16
0
0001662774
Cortexyme, Inc.
CRTX
0001376260
LOWE CHRISTOPHER P.
C/O CORTEXYME, INC.
269 EAST GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
COO & Chief Financial Officer
Common Stock
2021-11-16
4
M
0
30000
2.23
A
90000
D
Stock Option (right to buy)
2.23
2021-11-16
4
M
0
30000
0.00
D
2028-11-27
Common Stock
30000
103294
D
The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.
/s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
2021-11-16